维普中文期刊产品整合服务
4篇 您的检索式:作者名="Benjamin Buckley"
    题名 作者 年代 出处 被引量
1Fields,DVLC and panretinal hotocoagulation显示文摘Buckley SA Jenkins L Benjamin L 1992Eye1992,6,6:1
2Field loss after panretinal photocoagulation with diode and argon lasers显示文摘Buckley SA Jenkins L Benjamin L 1992Doc Ophthalmol1992,82,4:1
3Electrolytic cell engineering and device optimization for electrosynthesis of e-biofuels via co-valorisation of bio-feedstocks and captured CO_(2)显示文摘Utilizing CO_(2) in an electro-chemical process and synthesizing value-added chemicals are amongst the few viable and scalable pathways in carbon capture and utilization technologies.CO_(2) electro-reduction is also counted as one of the main options entailing less fossil fuel consumption and as a future electrical energy storage strategy.The current study aims at developing a new electrochemical platform to produce low-carbon e-biofuel through multifunctional electrosynthesis and integrated co-valorisation of biomass feedstocks with captured CO_(2).In this approach,CO_(2) is reduced at the cathode to produce drop-in fuels(e.g.,methanol)while value-added chemicals(e.g.,selective oxidation of alcohols,aldehydes,carboxylic acids and amines/amides)are produced at the anode.In this work,a numerical model of a continuous-flow design considering various anodic and cathodic reactions was built to determine the most techno-economically feasible configurations from the aspects of energy efficiency,environment impact and economical values.The reactor design was then optimized via parametric analysis.Faraz Montazersadgh Hao Zhang Anas Alkayal Benjamin Buckley Ben W.Kolosz Bing Xu Jin Xuan 2021Frontiers of Chemical Science and Engineering2021,15,1:1
4Magnetic sphincter augmentation: Optimal patient selection and referral care pathways显示文摘Outcomes associated with magnetic sphincter augmentation (MSA) in patients with gastroesophageal reflux disease (GERD) have been reported,however the optimal population for MSA and the related patient care pathways have not been summarized.This Minireview presents evidence that describes the optimal patient population for MSA,delineates diagnostics to identify these patients,and outlines opportunities for improving GERD patient care pathways.Relevant publications from MEDLINE/EMBASE and guidelines were identified from 2000-2018.Clinical experts contextualized the evidence based on clinical experience.The optimal MSA population may be the 2.2-2.4% of GERD patients who,despite optimal medical management,continue experiencing symptoms of heartburn and/or uncontrolled regurgitation,have abnormal pH,and have intact esophageal function as determined by high resolution manometry.Diagnostic work-ups include ambulatory pH monitoring,high-resolution manometry,barium swallow,and esophagogastroduodenoscopy.GERD patients may present with a range of typical or atypical symptoms.In addition to primary care providers (PCPs) and gastroenterologists (GIs),other specialties involved may include otolaryngologists,allergists,pulmonologists,among others.Objective diagnostic testing is required to ascertain surgical necessity for GERD.Current referral pathways for GERD management are suboptimal.Opportunities exist for enabling patients,PCPs,GIs,and surgeons to act as a team in developing evidence-based optimal care plans.F Paul Buckley Benjamin Havemann Amarpreet Chawla 2019World Journal of Gastrointestinal Endoscopy2019,11,8:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费